WVE News and Press, Wave Life Sciences Ltd. From 09/26/22

Summary Two new Breakout Stocks for Week 39 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now down to +108.7% YTD. This week no picks beat 10% gains in less than a week with SLCR peak at +7.1% and continuing the highest negative Mom...

Wave Life Sciences ( NASDAQ: WVE ) said a single dose of 30 mg or 60 mg WVE-003 helped reduce mutant huntingtin (mHTT) protein in cerebrospinal fluid (CSF) in patients with Huntington's disease (HD) who are in the early stages and carry SNP3 in association wit...

Single doses of WVE-003 appear generally safe and well-tolerated CSF mutant huntingtin (mHTT) protein was reduced following single doses of 30 or 60 mg; mean mHTT reduction across both cohorts was 22% (median reduction 30%) from baseline 85 days post-single dose Wild-type ...

CAMBRIDGE, Mass., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced it will hold an analyst and investor webcast on Wednesd...

Neptune Wellness Solutions ( NEPT ) +48% . ADDvantage Technologies Group ( AEY ) +33% Technologies GAAP EPS of $0.07, revenue of $27.79M. Larimar Therapeutics ( LRMR ) +31% on plans to resolve clinical hold on lead asset. Twin Vee Powercats ...

There was a great deal of life in Wave Life Sciences (NASDAQ: WVE) stock on Thursday. As of midafternoon trading, investors had bid the company's share price up by more than 25%, comparing very favorably to the marginal gain eked out by the S&P 500 index. That was due almost...

Wave Life Sciences Ltd. (WVE) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Kate Rausch - Head, Investor Relations Paul Bolno - President and Chief Executive Officer Mike Panzara - Chief Medical Officer Head, Therapeutics Discov...

Gainers: Digital Media Solutions ( DMS ) +133% . FlexShopper ( FPAY ) +72% . Absci ( ABSI ) +58% . Timber Pharmaceuticals ( TMBR ) +50% . T2 Biosystems ( TTOO ) +37% . Wave Life Sciences ( WVE ) +36% . Veru ( VE...

The following slide deck was published by Wave Life Sciences Ltd. in conjunction with their 2022 Q2 earnings call. For further details see: Wave Life Sciences Ltd. 2022 Q2 - Results - Earnings Call Presentation

Wave Life Sciences press release ( NASDAQ: WVE ): Q2 GAAP EPS of -$0.62 misses by $0.08 . Revenue of $0.37M (-86.7% Y/Y). As of June 30, 2022, Wave had $148.2 million in cash, cash equivalents and short-term investments For further details see:...